Literature DB >> 15660418

Differential regulation of platelet-derived growth factor stimulated migration and proliferation in osteoblastic cells.

Meenal Mehrotra1, Stephen M Krane, Kristen Walters, Carol Pilbeam.   

Abstract

Osteoblastic migration and proliferation in response to growth factors are essential for skeletal development, bone remodeling, and fracture repair, as well as pathologic processes, such as metastasis. We studied migration in response to platelet-derived growth factor (PDGF, 10 ng/ml) in a wounding model. PDGF stimulated a twofold increase in migration of osteoblastic MC3T3-E1 cells and murine calvarial osteoblasts over 24-48 h. PDGF also stimulated a tenfold increase in 3H-thymidine (3H-TdR) incorporation in MC3T3-E1 cells. Migration and DNA replication, as measured by BrdU incorporation, could be stimulated in the same cell. Blocking DNA replication with aphidicolin did not reduce the distance migrated. To examine the role of mitogen-activated protein (MAP) kinases in migration and proliferation, we used specific inhibitors of p38 MAP kinase, extracellular signal regulated kinase (ERK), and c-Jun N-terminal kinase (JNK). For these signaling studies, proliferation was measured by carboxyfluorescein diacetate succinimidyl ester (CFSE) using flow cytometry. Inhibition of the p38 MAP kinase pathway by SB203580 and SB202190 blocked PDGF-stimulated migration but had no effect on proliferation. Inhibition of the ERK pathway by PD98059 and U0126 inhibited proliferation but did not inhibit migration. Inhibition of JNK activity by SP600125 inhibited both migration and proliferation. Hence, the stimulation of migration and proliferation by PDGF occurred by both overlapping and independent pathways. The JNK pathway was involved in both migration and proliferation, whereas the p38 pathway was predominantly involved in migration and the ERK pathway predominantly involved in proliferation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15660418     DOI: 10.1002/jcb.20138

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  26 in total

1.  Skeletal unloading-induced insulin-like growth factor 1 (IGF-1) nonresponsiveness is not shared by platelet-derived growth factor: the selective role of integrins in IGF-1 signaling.

Authors:  Roger K Long; Shigeki Nishida; Takuo Kubota; Yongmei Wang; Takeshi Sakata; Hashem Z Elalieh; Bernard P Halloran; Daniel D Bikle
Journal:  J Bone Miner Res       Date:  2011-12       Impact factor: 6.741

2.  Phosphorylation of GIT1 tyrosine 321 is required for association with FAK at focal adhesions and for PDGF-activated migration of osteoblasts.

Authors:  Yongxin Ren; Lipeng Yu; Jin Fan; Ze Rui; Zhengzhe Hua; Zitao Zhang; Ning Zhang; Guoyong Yin
Journal:  Mol Cell Biochem       Date:  2012-06       Impact factor: 3.396

Review 3.  Osteoblast migration in vertebrate bone.

Authors:  Antonia Thiel; Marie K Reumann; Adele Boskey; Johannes Wischmann; Rüdiger von Eisenhart-Rothe; Philipp Mayer-Kuckuk
Journal:  Biol Rev Camb Philos Soc       Date:  2017-06-19

4.  Enhanced osteoblastogenesis in three-dimensional collagen gels.

Authors:  Brya G Matthews; Dorit Naot; Karen E Callon; David S Musson; Rachel Locklin; Philippa A Hulley; Andrew Grey; Jillian Cornish
Journal:  Bonekey Rep       Date:  2014-08-06

5.  Cediranib inhibits both the intraosseous growth of PDGF D-positive prostate cancer cells and the associated bone reaction.

Authors:  Abdo J Najy; Young Suk Jung; Joshua J Won; M Katie Conley-LaComb; Allen Saliganan; Chong Jai Kim; Elisabeth Heath; Michael L Cher; R Daniel Bonfil; Hyeong-Reh Choi Kim
Journal:  Prostate       Date:  2011-12-27       Impact factor: 4.104

6.  Enhanced Bone Repair by Guided Osteoblast Recruitment Using Topographically Defined Implant.

Authors:  Jeong-Kee Yoon; Hong Nam Kim; Suk Ho Bhang; Jung-Youn Shin; Jin Han; Wan-Geun La; Gun-Jae Jeong; Seokyung Kang; Ju-Ro Lee; Jaesur Oh; Min Sung Kim; Noo Li Jeon; Byung-Soo Kim
Journal:  Tissue Eng Part A       Date:  2016-03-31       Impact factor: 3.845

7.  MiR-29a Assists in Preventing the Activation of Human Stellate Cells and Promotes Recovery From Liver Fibrosis in Mice.

Authors:  Yoshinari Matsumoto; Saori Itami; Masahiko Kuroda; Katsutoshi Yoshizato; Norifumi Kawada; Yoshiki Murakami
Journal:  Mol Ther       Date:  2016-06-23       Impact factor: 11.454

8.  p38MAPK controls fibroblast growth factor 23 (FGF23) synthesis in UMR106-osteoblast-like cells and in IDG-SW3 osteocytes.

Authors:  F Ewendt; M Föller
Journal:  J Endocrinol Invest       Date:  2019-06-14       Impact factor: 4.256

9.  PI3K/AKT pathway involvement in the osteogenic effects of osteoclast culture supernatants on preosteoblast cells.

Authors:  Li-Li Chen; Mei Huang; Jing-Yi Tan; Xiao-Tao Chen; Li-Hong Lei; Yan-Min Wu; Di-Ya Zhang
Journal:  Tissue Eng Part A       Date:  2013-05-30       Impact factor: 3.845

10.  PDGFR-A is a therapeutic target in alveolar rhabdomyosarcoma.

Authors:  E Taniguchi; K Nishijo; A T McCleish; J E Michalek; M H Grayson; A J Infante; H E Abboud; R D Legallo; S J Qualman; B P Rubin; C Keller
Journal:  Oncogene       Date:  2008-08-04       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.